-
://incit.fr/ ) are gathered around a common objective aiming to develop new immunotherapy strategies in different pathological contexts, such as solid tumors, inflammatory and infectious diseases. Our Unit
-
, pancreas, etc.) using an integrated approach to disease. In most of these contexts, the immune system plays a central role, with pathological disorders frequently associated with secondary inflammation and
-
severity, anticipating health risks and contributing to the development of prevention and management strategies adapted to tropical and island contexts. Strategy of the host laboratory: From January 2026
-
at strengthening public awareness and understanding of research, and to support the development of an ambitious communication strategy designed to increase the visibility and impact of the research center’s work
-
the central role of immunity in the cancer fight. Although revolutionary, this therapeutic approach does not yet provide the expected results for all patients. In this context, the team TICI (Therapuetic
-
clinical practices and prevention. The research and results of the chair will also be communicated to patients and the public. In this context, the original results obtained will be shared with the public
-
. This approach will be applied in vitro to study the spatiotemporal organization of fundamental biological functions (division, transcription, trafficking, etc.) in single-celled organisms in various contexts
-
, Interoperable, Reusable) for the data produced. Science and society: The aim is to raise awareness of the challenges of immunothrombosis and the importance of developing new targeted therapies. We aim